Preanesthetic dexmedetomidine 1 μg/kg single infusion is a simple, easy, and economic adjuvant for general anesthesia
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Shin, H.W. | - |
dc.contributor.author | Yoo, H.N. | - |
dc.contributor.author | Kim, D.H. | - |
dc.contributor.author | Lee, H. | - |
dc.contributor.author | Shin, H.J. | - |
dc.contributor.author | Lee, H.W. | - |
dc.date.accessioned | 2021-09-06T09:44:45Z | - |
dc.date.available | 2021-09-06T09:44:45Z | - |
dc.date.created | 2021-06-17 | - |
dc.date.issued | 2013 | - |
dc.identifier.issn | 2005-6419 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/105885 | - |
dc.description.abstract | Background: Dexmedetomidine is an α2-adrenoreceptor agonist with sedative, analgesic and anxiolytic effects, and it has more selective α2-adrenergic effect than clonidine. We evaluate the effect of preansethetic dexmedetomidine 1 μg/kg single infusion on sedation, hemodynamics, anesthetic consumption, and recovery profiles during anesthesia. Methods: Forty-two female patients with American Society of Anesthesiologists physical status I or II undergoing gynecologic surgery with anticipated operation time of 2 h, were randomly assigned to receive dexmedetomidine 1 μg/kg (Dex group) or saline (control group) iv over 10 min before anesthetic induction. After tracheal intubation with propofol 2 mg/kg, cisatracurium 0.15 mg/kg iv, anesthesia was maintained with sevoflurane, O2 50%, N2O 50% around a BIS value of 40. Results: After study drug infusion, BIS of Dex group was lower than that of control group (93.9 ± 3.1 vs 51.5 ± 5.2, P < 0.05). Mean arterial pressure (MAP) and heart rate (HR) after intubation were increased in control group, but did not change in Dex group. During maintenance, there was no difference in MAP between groups, but HR of Dex group was lower compared to that of control group. End-tidal concentration (2.0 ± 0.5 vol% vs 1.4 ± 0.3 vol%, P < 0.05) and total cumulative consumption of sevoflurane (34.6 ± 3.8 ml vs 26.5 ± 5.3 ml, P < 0.05) were lower in Dex group than in control group. Recovery profiles, modified Aldrete score, postoperative nausea vomiting, and visual analogue pain score were not significantly different between groups. Conclusions: Preanesthetic dexmetomidine 1 μg/kg single infusion is a simple, easy, and economic general anesthetic adjuvant that maintains stable hemodynamics and decrease anesthetic consumption without the change of recovery profiles. © the Korean Society of Anesthesiologists, 2013. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.subject | cisatracurium | - |
dc.subject | dexmedetomidine | - |
dc.subject | ephedrine | - |
dc.subject | fentanyl | - |
dc.subject | glycopyrronium bromide | - |
dc.subject | propofol | - |
dc.subject | sevoflurane | - |
dc.subject | adult | - |
dc.subject | anesthesia level | - |
dc.subject | anesthetic recovery | - |
dc.subject | article | - |
dc.subject | bispectral index | - |
dc.subject | clinical article | - |
dc.subject | controlled study | - |
dc.subject | double blind procedure | - |
dc.subject | electrocardiogram | - |
dc.subject | endotracheal intubation | - |
dc.subject | female | - |
dc.subject | heart rate | - |
dc.subject | human | - |
dc.subject | mean arterial pressure | - |
dc.subject | pain assessment | - |
dc.subject | pulse oximeter | - |
dc.subject | randomized controlled trial | - |
dc.title | Preanesthetic dexmedetomidine 1 μg/kg single infusion is a simple, easy, and economic adjuvant for general anesthesia | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Shin, H.W. | - |
dc.contributor.affiliatedAuthor | Shin, H.J. | - |
dc.contributor.affiliatedAuthor | Lee, H.W. | - |
dc.identifier.doi | 10.4097/kjae.2013.65.2.114 | - |
dc.identifier.scopusid | 2-s2.0-84883759181 | - |
dc.identifier.bibliographicCitation | Korean Journal of Anesthesiology, v.65, no.2, pp.114 - 120 | - |
dc.relation.isPartOf | Korean Journal of Anesthesiology | - |
dc.citation.title | Korean Journal of Anesthesiology | - |
dc.citation.volume | 65 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 114 | - |
dc.citation.endPage | 120 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART001794651 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.subject.keywordPlus | cisatracurium | - |
dc.subject.keywordPlus | dexmedetomidine | - |
dc.subject.keywordPlus | ephedrine | - |
dc.subject.keywordPlus | fentanyl | - |
dc.subject.keywordPlus | glycopyrronium bromide | - |
dc.subject.keywordPlus | propofol | - |
dc.subject.keywordPlus | sevoflurane | - |
dc.subject.keywordPlus | adult | - |
dc.subject.keywordPlus | anesthesia level | - |
dc.subject.keywordPlus | anesthetic recovery | - |
dc.subject.keywordPlus | article | - |
dc.subject.keywordPlus | bispectral index | - |
dc.subject.keywordPlus | clinical article | - |
dc.subject.keywordPlus | controlled study | - |
dc.subject.keywordPlus | double blind procedure | - |
dc.subject.keywordPlus | electrocardiogram | - |
dc.subject.keywordPlus | endotracheal intubation | - |
dc.subject.keywordPlus | female | - |
dc.subject.keywordPlus | heart rate | - |
dc.subject.keywordPlus | human | - |
dc.subject.keywordPlus | mean arterial pressure | - |
dc.subject.keywordPlus | pain assessment | - |
dc.subject.keywordPlus | pulse oximeter | - |
dc.subject.keywordPlus | randomized controlled trial | - |
dc.subject.keywordAuthor | Dexmedetomidine | - |
dc.subject.keywordAuthor | Economics | - |
dc.subject.keywordAuthor | Hemodynamics | - |
dc.subject.keywordAuthor | Recovery of function | - |
dc.subject.keywordAuthor | Sevoflurane | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.